November 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreFebruary 27, 2026
Our projections indicate that, the antibody-drug conjugates (ADCs) CMO and CDMO market was valued at USD 9.93 billion in 2025 and reached USD 11.08 billion in 2026, and it is projected to grow to USD 29.65 billion by 2035, expanding at a CAGR of 11.56% from 2026 to 2035....
February 27, 2026
Our projections indicate, the small molecule CMO and CDMO market was valued at USD 75.8 billion in 2025 and is projected to grow from USD 79.7 billion in 2026 to USD 125.13 billion by 2035, expanding at a CAGR of 5.14% during 2026–2035....
February 27, 2026
Based on market forecasts, the U.S. supplemental health sector will expand from USD 40.8 billion in 2025 to USD 70.62 billion by 2035, experiencing a CAGR of 5.64%. Increasing health awareness and focus on preventive care are estimated to drive the growth of the market....
February 27, 2026
According to market projections, the clinical trials sector is expected to grow from USD 92.88 billion in 2025 to USD 174.18 billion by 2035, reflecting a CAGR of 5.7%. Growth in the clinical trials market is driven by global government support, improved R&D, advanced technology, and streamlined regulations. With rising studies worldwide, innov...
February 27, 2026
According to market projections, the clinical trails sector is expected to grow from USD 92.88 billion in 2025 to USD 174.18 billion by 2035, reflecting a CAGR of 5.7%. Growing R&D in chronic disease and novel therapies, increased investments, favorable policies, and advanced tech drive the clinical trials market....
February 26, 2026
Based on market forecasts, the bioanalytical testing services sector will expand from USD 4.54 billion in 2025 to USD 18.66 billion by 2035, experiencing a CAGR of 15.54%. The increasing number of clinical trials and technological advancements drives the global market. The presence of key players and state-of-the-art research and development facili...
February 26, 2026
Projections indicate that, North America central lab industry is projected to rise from USD 1.46 billion in 2025 to USD 2.54 billion by 2035, reflecting a CAGR of 5.71% over the next decade. The presence of a favorable clinical trial infrastructure and regulatory support drives the market. The dominance of the U.S. is attributed to the presence of ...
February 26, 2026
According to market projections, the E-pharmacy sector is expected to grow from USD 112.88 billion in 2025 to USD 517.16 billion by 2035, reflecting a CAGR of 16.44%. The E-pharmacy market is growing due to rising government support for e-healthcare services. North America is dominant in the market due to its advanced healthcare infrastructure and ...
February 26, 2026
Based on market forecasts, the global healthcare companion robots market, projected at USD 3.14 billion in 2025, is expected to reach USD 16.49 billion by 2035, growing at a CAGR of 18.04% over the forecast period.The market is growing due to rising demand for elderly care and patient monitoring, along with advancements in AI and robotics, enabling...
February 25, 2026
Market insights predict, the cardiac ablation industry is expected to grow from USD 5.88 billion in 2025 to USD 22.27 billion by 2035, driven by a CAGR of 14.24%. A global surge in minimally invasive approaches is propelling the global market. The growing AF prevalence is fueling North America's dominance....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com